Sofosbuvir and Daclatasvir for Treating Hepatitis C in 200 Patients Co-infected With Human Immunodeficiency Virus

Clinical trial NCT03369327 · COMPLETED

Trial details

NCT number: NCT03369327
Sponsor: Tehran University of Medical Sciences
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatitis C Virus Infection, Response to Therapy of Human Immunodeficiency Virus

Start date: 2017-01-01
Primary completion: 2018-09-01
Enrollment: 232

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.